首页> 外国专利> DIAGNOSTIC TECHNIQUE FOR PERSISTENT LATENT BACTERIAL INFECTION WITH ASSOCIATING VESSEL WALL INVOLVEMENT

DIAGNOSTIC TECHNIQUE FOR PERSISTENT LATENT BACTERIAL INFECTION WITH ASSOCIATING VESSEL WALL INVOLVEMENT

机译:伴有血管壁介入的持续潜伏细菌感染的诊断技术

摘要

FIELD: medicine.;SUBSTANCE: after provisional diagnosing of a vascular disease, patient's blood serum is analysed for beta2-glycoprotein 1 antibodies (B2GPab), endothelium antibodies (Eab), Clq complement factor antibodies (Clq ab), cryoglobulins (CG) in the form of cryocrit and activity of rheumatoid factor (RF). If B2GPab is equal to 5 standard unit/ml and more, Eab is equal to 1:10 and more, Clq ab is equal to 5 standard unit/ml and more, CG in the form of cryocrit is more than 0%, RF is equal to 1:20 and more, therapeutic intervention which involves four daily procedures of leucopheresis with klion autoleukocyte adsorption in a single dose 500 mg combined with oral administration of biseptol in a single dose 480 mg is executed. After 4-5 weeks from the beginning of therapy, control blood examination for infection agents with the use of culture and genetic diagnostic techniques follows. If observing bacterial agents, persistent latent bacterial infection with associating vessel wall involvement is diagnosed.;EFFECT: higher diagnostic accuracy of chronic latent bacterial infection with associating vessel wall involvement.;3 tbl, 3 ex
机译:领域:药物:物质:临时诊断出血管疾病后,分析患者的血清中的β2-糖蛋白1抗体(B2GPab),内皮抗体(Eab),Clq补体因子抗体(Clq ab),冷冻球蛋白(CG)冷冻比容和类风湿因子(RF)的活性。如果B2GPab等于或等于5个标准单位/毫升,Eab等于或大于1:10,Clq ab等于或等于5标准单位/毫升,冷冻比容计形式的CG大于0%,RF为等于1:20或更高,将执行涉及四项白斑切除术的每日每日程序,其中单剂量500 mg的klion自体白细胞吸附结合单剂量480 mg的双庚酚口服给药。从治疗开始4-5周后,即可使用培养和基因诊断技术对感染剂进行对照血液检查。如果观察细菌制剂,则可诊断出伴有血管壁受累的持续性潜伏细菌感染。效果:伴有血管壁受累的慢性潜伏细菌感染的诊断准确性更高; 3 tbl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号